Christine is being treated for secondary breast cancer with the innovative new drug palbociclib.
The first patient has been treated, as part of a clinical trial, with an innovative new technology called Acoustic Cluster Therapy.
Professor Gail ter Haar's team are working with industrial partners to help advance their research and get new techniques to patients faster.
Professor Pines’ team collaborate with companies to develop new equipment and novel techniques that can help them to push the boundaries further than ever before.
Some of our leading early-career researchers discuss the benefits of becoming a team leader at the ICR – from a vibrant and diverse multi-disciplinary culture and dedicated career support, to our outstanding scientific facilities and services.
Senior scientists and early-career researchers introduce working at the ICR. Our team leaders enjoy top-class scientific facilities and career support.
Our world-class research facilities include our platform technologies in areas such as microscopy, genomic sequencing, flow cytometry, proteomics, cryo-EM, and the computing and data storage infrastructure.
We are creating a new state-of-the-art drug discovery centre to create more and better drugs for cancer patients. We now have less than £14m to raise and urgently need your support.
Professor Isacke, Molecular Cell Biology Team Leader, and Joint Chair of the NCRI Scientific Committee looks ahead to the next year of cancer research.